2:21 PM ET
Earnings Call
▶ Call
Castle Biosciences Earnings Call: Key Takeaways
Castle Biosciences delivered a strong Q3 2026 beat, raising full-year revenue guidance by $20 million driven by 47% volume growth in TissueCypher.
- Call
- Nov 5, 2026, 4:30 PM ET